Lineage Cell Therapeutics, Inc.
LCTX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000876343
No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Lineage Cell Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 127
- +3 vs. Q4 2024
- Shares held
- 109.4M
- +2.74M (+2.6%) vs. Q4 2024
- Total value
- $49.7M
- −$3.89M (−7.3%) vs. Q4 2024
- New holders
- 19
- 37 more added
- Sold out
- 16
- 22 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 131 | $152.7M |
| Q1 2026 | 130 | $176.5M |
| Q4 2025 | 123 | $169.8M |
| Q3 2025 | 112 | $148.6M |
| Q2 2025 | 129 | $88.4M |
| Q1 2025 | 127 | $49.7M |
| Q4 2024 | 126 | $53.8M |
| Q3 2024 | 114 | $85.6M |
| Q2 2024 | 113 | $94.2M |
| Q1 2024 | 116 | $138.3M |
| Q4 2023 | 115 | $82.5M |
| Q3 2023 | 104 | $89.1M |
| Q2 2023 | 107 | $106.6M |
| Q1 2023 | 116 | $104.7M |
| Q4 2022 | 106 | $76.2M |
| Q3 2022 | 104 | $73.1M |
| Q2 2022 | 100 | $102.7M |
| Q1 2022 | 109 | $112.3M |
| Q4 2021 | 124 | $182.0M |
| Q3 2021 | 115 | $191.7M |
| Q2 2021 | 115 | $208.5M |
| Q1 2021 | 102 | $141.8M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Lineage Cell Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quadrant Private Wealth Management, LLC | 10,000 | $4.52K | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 10,000 | $4.52K | 0.00% | +10,000 | New |
| BNP Paribas Arbitrage, SA | 9,579 | $4.33K | 0.00% | −9,520−49.8% | Reduced |
| SBI Securities Co., Ltd. | 8,601 | $3.88K | 0.00% | +1,900+28.4% | Added |
| Amalgamated Bank | 4,351 | $2.00K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 4,439 | $2.00K | 0.00% | +2,681+152.5% | Added |
| New York State Common Retirement Fund | 3,319 | $1.50K | 0.00% | 00.0% | Unchanged |
| Albion Financial Group | 3,043 | $1.38K | 0.00% | 00.0% | Unchanged |
| Pacifica Partners Inc. | 2,926 | $1.22K | 0.00% | 00.0% | Unchanged |
| Ameriflex Group, Inc. | 2,200 | $994 | 0.00% | 00.0% | Unchanged |
| Trust Co of Vermont | 1,553 | $701 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 1,250 | $570 | 0.00% | 00.0% | Unchanged |
| Riggs Asset Managment Co. Inc. | 1,000 | $452 | 0.00% | 00.0% | Unchanged |
| Wolff Wiese Magana LLC | 1,000 | $452 | 0.00% | +1,000 | New |
| Nisa Investment Advisors, LLC | 928 | $419 | 0.00% | −565−37.8% | Reduced |
| Jones Financial Companies LLLP | 700 | $344 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 429 | $176 | 0.00% | +429 | New |
| Sterling Capital Management LLC | 150 | $68 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 111 | $50 | 0.00% | +111 | New |
| True Wealth Design, LLC | 96 | $44 | 0.00% | +96 | New |
| Rossby Financial, LCC | 58 | $28 | 0.00% | +58 | New |
| The PNC Financial Services Group, Inc. | 46 | $21 | 0.00% | +38+475.0% | Added |
| Strategic Investment Solutions, Inc. | 44 | $20 | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 29 | $13 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 3 | $1 | 0.00% | 00.0% | Unchanged |
| St Germain D J Co Inc | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Hantz Financial Services, Inc. | 29 | $0 | 0.00% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −7,236,843−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −3,947,369−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −1,033,763−100.0% | Sold out |
| Prescott General Partners LLC | 0 | $0 | 0.00% | −386,000−100.0% | Sold out |
| DCF Advisers, LLC | 0 | $0 | 0.00% | −107,751−100.0% | Sold out |
| Atria Wealth Solutions, Inc. | 0 | $0 | 0.00% | −57,423−100.0% | Sold out |
| United Bank | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Asset Planning,Inc | 0 | $0 | 0.00% | −2,036−100.0% | Sold out |
| Sugar Maple Asset Management, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| FLP Wealth Management, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Plante Moran Financial Advisors, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −148−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −351−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| RE Dickinson Investment Advisors, LLC | – | – | – | – | Not filed |